| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer
|
Au, E.
|
|
|
9 |
3 |
p. 327-329
|
article
|
| 2 |
Activity of paclitaxel by three-hour infusion in Asian patients withmetastatic undifferentiated nasopharyngeal cancer
|
E. Au
|
|
1998
|
9 |
3 |
p. 327-329
3 p.
|
article
|
| 3 |
After AACR request, Clinton to propose big increase for NCI
|
|
|
|
9 |
3 |
p. 235
|
article
|
| 4 |
A successful merger
|
|
|
|
9 |
3 |
p. 233-234
|
article
|
| 5 |
Awards, appointments
|
|
|
|
9 |
3 |
p. 235
|
article
|
| 6 |
Book review
|
Bernier, J.
|
|
|
9 |
3 |
p. 238
|
article
|
| 7 |
Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck
|
Thödtmann, R.
|
|
|
9 |
3 |
p. 335-337
|
article
|
| 8 |
Coincidence of seminoma and sarcoidosis: A myth or fact?
|
Tjan-Heijnen, V.C.G.
|
|
|
9 |
3 |
p. 321-325
|
article
|
| 9 |
Coincidence of seminoma and sarcoidosis: A myth or fact?
|
V. C. G. Tjan-Heijnen
|
|
1998
|
9 |
3 |
p. 321-325
5 p.
|
article
|
| 10 |
Comparison of psychosocial adaptation of advanced stage Hodgkin’s disease and acute leukemia survivors
|
Kornblith, A.B.
|
|
|
9 |
3 |
p. 297-306
|
article
|
| 11 |
Comparison of psychosocial adaptation of advanced stage Hodgkins diseaseand acute leukemia survivors
|
A. B. Kornblith
|
|
1998
|
9 |
3 |
p. 297-306
10 p.
|
article
|
| 12 |
Contents of the next issue
|
|
|
|
9 |
3 |
p. v
|
article
|
| 13 |
Copyright
|
|
|
|
9 |
3 |
p. iii
|
article
|
| 14 |
Corrigendum
|
Herrmann, R.
|
|
|
9 |
3 |
p. 342
|
article
|
| 15 |
Corrigendum
|
Lokich, J.
|
|
|
9 |
3 |
p. 341
|
article
|
| 16 |
Detection of identical Hodgkin–Reed Sternberg cell specific immunoglobulin gene rearrangements in a patient with Hodgkin’s disease of mixed cellularity subtype at primary diagnosis and in relapse two and a half years later
|
Jox, A.
|
|
|
9 |
3 |
p. 283-287
|
article
|
| 17 |
Detection of identical HodgkinReed Sternberg cell specificimmunoglobulin gene rearrangements in a patient with Hodgkins disease ofmixed cellularity subtype at primary diagnosis and in relapse two and a halfyears later
|
A. Jox
|
|
1998
|
9 |
3 |
p. 283-287
5 p.
|
article
|
| 18 |
Determination and validation of a predictive model for Clostridiumdifficile diarrhea in hospitalized oncology patients
|
K. Hornbuckle
|
|
1998
|
9 |
3 |
p. 307-311
5 p.
|
article
|
| 19 |
Determination and validation of a predictive model for Clostridium difficile diarrhea in hospitalized oncology patients
|
Hornbuckle,
|
|
|
9 |
3 |
p. 307-311
|
article
|
| 20 |
DNA-topoisomerase I activity and content in epithelial ovarian cancer
|
Codegoni, A.M.
|
|
|
9 |
3 |
p. 313-318
|
article
|
| 21 |
Dna-topoisomerase I activity and content in epithelial ovariancancer
|
A. M. Codegoni
|
|
1998
|
9 |
3 |
p. 313-319
7 p.
|
article
|
| 22 |
Does bone marrow involvement affect prognosis in small-cell lung cancer?
|
Pasini, F.
|
|
|
9 |
3 |
p. 247-250
|
article
|
| 23 |
Does bone marrow involvement affect prognosis in small-cell lungcancer?
|
F. Pasini
|
|
1998
|
9 |
3 |
p. 247-250
4 p.
|
article
|
| 24 |
Editorial board
|
|
|
|
9 |
3 |
p. iv
|
article
|
| 25 |
Favorable outcome of patients with relapsed or refractory Hodgkin’s disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dexa-BEAM)
|
Josting, A.
|
|
|
9 |
3 |
p. 289-295
|
article
|
| 26 |
Favorable outcome of patients with relapsed or refractory Hodgkinsdisease treated with high-dose chemotherapy and stem cell rescue at the timeof maximal response to conventional salvage therapy (Dexa-BEAM)
|
A. Josting
|
|
1998
|
9 |
3 |
p. 289-295
7 p.
|
article
|
| 27 |
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: A multicenter phase II study
|
Georgoulias, V.
|
|
|
9 |
3 |
p. 331-334
|
article
|
| 28 |
First-line treatment of advanced non-small-cell lung cancer withdocetaxel and cisplatin: A multicenter phase II study
|
V. Georgoulias
|
|
1998
|
9 |
3 |
p. 331-334
4 p.
|
article
|
| 29 |
Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma
|
Middleton, G.W.
|
|
|
9 |
3 |
p. 269-273
|
article
|
| 30 |
Good symptom relief with palliative MVP (mitomycin-C, vinblastine andcisplatin) chemotherapy in malignant mesothelioma
|
G. W. Middleton
|
|
1998
|
9 |
3 |
p. 269-273
5 p.
|
article
|
| 31 |
H. W. Vahrson (ed)., Radiation oncology of gynecological cancers
|
J. Bernier
|
|
1998
|
9 |
3 |
p. 238-238
1 p.
|
article
|
| 32 |
International committee to investigate trial of Italian ‘miraculous cure’
|
|
|
|
9 |
3 |
p. 234-235
|
article
|
| 33 |
In this Issue
|
|
|
|
9 |
3 |
p. v
|
article
|
| 34 |
J. Lokich & N. Anderson. Carboplatin versus cisplatin in solidtumors: An analysis of the literature. Ann Oncol 1998; 9: 1321.
|
|
|
1998
|
9 |
3 |
p. 341-341
1 p.
|
article
|
| 35 |
MAMM: The first magazine devoted to breast cancer
|
|
|
|
9 |
3 |
p. 234
|
article
|
| 36 |
New NHS should improve cancer care
|
|
|
|
9 |
3 |
p. 233
|
article
|
| 37 |
New NHS should improve cancer care; A successful merger; MAMM: The firstmagazine devoted to breast cancer; International committee to investigatetrial of Italian miraculous cure; After AACR request, Clinton to propose bigincrease for NCI; Awards, appointments; Perhaps not everyone knowsthat...
|
|
|
1998
|
9 |
3 |
p. 233-237
5 p.
|
article
|
| 38 |
One community
|
Wittes, R.E.
|
|
|
9 |
3 |
p. 251-254
|
article
|
| 39 |
One community
|
R. E. Wittes
|
|
1998
|
9 |
3 |
p. 251-254
4 p.
|
article
|
| 40 |
Perhaps not everyone knows that…
|
|
|
|
9 |
3 |
p. 235-237
|
article
|
| 41 |
Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies
|
Paulussen, M.
|
|
|
9 |
3 |
p. 275-281
|
article
|
| 42 |
Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171patients from the EICESS studies
|
M. Paulussen
|
|
1998
|
9 |
3 |
p. 275-281
7 p.
|
article
|
| 43 |
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study
|
Oberhoff, C.
|
|
|
9 |
3 |
p. 255-260
|
article
|
| 44 |
Recombinant human erythropoietin in the treatment of chemotherapy-inducedanemia and prevention of transfusion requirement associated with solid tumors:A randomized, controlled study
|
C. Oberhoff
|
|
1998
|
9 |
3 |
p. 255-260
6 p.
|
article
|
| 45 |
R. Herrmann. 5-Fluorouracil and mitomycin-C in colorectal cancer: Unacceptable conclusion. Ann Oncol 1998;9:230
|
|
|
1998
|
9 |
3 |
p. 342-342
1 p.
|
article
|
| 46 |
Table of Contents
|
|
|
|
9 |
3 |
p. ii-iii
|
article
|
| 47 |
The current state of the art in treating stage IIIA (N2) lung cancer
|
Martini, N.
|
|
|
9 |
3 |
p. 243-245
|
article
|
| 48 |
The current state of the art in treating stage IIIA (N2) lungcancer
|
N. Martini, MD
|
|
1998
|
9 |
3 |
p. 243-245
3 p.
|
article
|
| 49 |
Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy
|
Gross, T.G.
|
|
|
9 |
3 |
p. 339-340
|
article
|
| 50 |
Treatment of post-transplant lymphoproliferative disease (PTLD) followingsolid organ transplantation with low-dose chemotherapy
|
Thomas G. Gross
|
|
1998
|
9 |
3 |
p. 339-340
2 p.
|
article
|
| 51 |
Vindesine–ifosfamide–platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: A prospective study
|
Vansteenkiste, J.F.
|
|
|
9 |
3 |
p. 261-267
|
article
|
| 52 |
What is the role of erythropoietin in patients with solid tumours?
|
Maraveyas, A.
|
|
|
9 |
3 |
p. 239-241
|
article
|
| 53 |
What is the role of erythropoietin in patients with solid tumours?
|
A. Maraveyas
|
|
1998
|
9 |
3 |
p. 239-241
3 p.
|
article
|
Journal description